06 June 2025
06 June 2025
A study found no rise in ADHD cases, though some drugs for the disorder are still in shortage amid high demand.
The authorisation is supported by data from the company鈥檚 pivotal Phase III STAR trial.
Regeneron and Sanofi鈥檚 blockbuster Dupixent has transformed the atopic dermatitis market, with future disruptors in the pipeline.
Roche and Vividion discovered and developed the therapy through a 2020 global partnership and licence agreement.
The partnership will integrate Molecular Health鈥檚 digital drug development platform into Axxam's integrated early drug discovery process.
The platform enables evaluation of drug targets based on therapeutic, biological and market potential.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
